arXiv subjects

Jake Y. Chen

Publications and source records attributed to Jake Y. Chen.

5 recordsLinked to original sources

arXiv2026

Structured Proxy Features for Multimodal NSCLC Survival Prediction from Pretreatment CT

Lung cancer results in roughly 1.8 million fatalities annually worldwide, with non-small cell lung cancer (NSCLC) comprising the majority of cases. Despite advancements in treatment, survival stratification remains challenging due to intratumoral heterogeneity inadequately captured by conventional descriptors. Standard radiomic and deep learning techniques regard imaging features as independent quantities, overlooking structured interactions between tumor characteristics. We evaluate whether structured proxy features can enhance multimodal NSCLC survival prediction by augmenting pretreatment computed tomography (CT) representations, radiomics, and clinical variables with six simulation-derived features designed to capture interactions between heterogeneity and morphology. A radiomic-parameterized cellular automaton generates growth-rate and necrosis-ratio proxy features from baseline CT by using entropy and sphericity to compute low-dimensional proxy parameters. The imaging backbone is a Transformer-based Masked Autoencoder (TMAE), which was chosen after a systematic evaluation with alternative encoders within the same pipeline and provides attention-based visualizations that highlight tumor regions receiving higher model attention. On the public Lung1 cohort (n = 390), the primary four-modality fusion attained a C-index of 0.641 (iAUC 0.731, log-rank p < 0.001). The primary result compares favorably with prior multimodal results on Lung1 (C-index 0.631; iAUC 0.592 [15]) under a comparable evaluation protocol, while a separate exploratory coefficient-optimization analysis achieved a best observed C-index of 0.662 (iAUC 0.748). These results indicate that, in addition to conventional radiomic, deep, and clinical representations within the Lung1 benchmark, simulation-derived proxy features may provide complementary predictive information within this fixed Lung1 benchmark.

cs.CV↗

arXiv2026

SVC-Probe: A Framework for Evaluating Perturbation Generalization in Spatial Foundation-Model Embeddings

This work examines perturbation generalization in spatial foundation-model embeddings derived from fluorescence microscopy images. Although these models can discriminate drug conditions accurately, it remains unclear whether the learned representations reflect patterns consistent with expected perturbation axes that transfer across drugs. We introduce SVC-Probe, a perturbation-aware framework that combines Subcellular Embedding Atlas Stability, Mondrian Neighborhood Graphs, and a Foundation Model Perturbation Probe to assess embedding stability, neighborhood rewiring, and centroid prediction under drug treatment. Applied to the CM4AI MDA-MB-468 chemical-perturbation atlas comprising 462 antibody labels and SubCell 1536-dimensional embeddings, SVC-Probe demonstrates that 98.6% three-way condition accuracy does not correlate with reliable cross-drug prediction, with cosine similarity diminishing from 0.944 in-domain to 0.30 under leave-one-drug-out evaluation, constituting a two-drug stress test rather than a general benchmark. Null calibration indicates that raw residual-turnover coupling is largely influenced by generic embedding structure, whereas a drug-specific signal emerges under vorinostat and is consistent with chromatin-related reorganization. In contrast, the paclitaxel axis is not robustly reconstructed, likely due to sparse coverage of microtubule-associated proteins. Together, these results introduce and demonstrate a reusable diagnostic framework for stress-testing spatial virtual-cell representations and indicate that perturbation generalization may serve as a stricter and more informative benchmark than baseline condition discrimination.

q-bio.QM↗

arXiv2025

Llama-Affinity: A Predictive Antibody Antigen Binding Model Integrating Antibody Sequences with Llama3 Backbone Architecture

Antibody-facilitated immune responses are central to the body's defense against pathogens, viruses, and other foreign invaders. The ability of antibodies to specifically bind and neutralize antigens is vital for maintaining immunity. Over the past few decades, bioengineering advancements have significantly accelerated therapeutic antibody development. These antibody-derived drugs have shown remarkable efficacy, particularly in treating cancer, SARS-CoV-2, autoimmune disorders, and infectious diseases. Traditionally, experimental methods for affinity measurement have been time-consuming and expensive. With the advent of artificial intelligence, in silico medicine has been revolutionized; recent developments in machine learning, particularly the use of large language models (LLMs) for representing antibodies, have opened up new avenues for AI-based design and improved affinity prediction. Herein, we present an advanced antibody-antigen binding affinity prediction model (LlamaAffinity), leveraging an open-source Llama 3 backbone and antibody sequence data sourced from the Observed Antibody Space (OAS) database. The proposed approach shows significant improvement over existing state-of-the-art (SOTA) methods (AntiFormer, AntiBERTa, AntiBERTy) across multiple evaluation metrics. Specifically, the model achieved an accuracy of 0.9640, an F1-score of 0.9643, a precision of 0.9702, a recall of 0.9586, and an AUC-ROC of 0.9936. Moreover, this strategy unveiled higher computational efficiency, with a five-fold average cumulative training time of only 0.46 hours, significantly lower than in previous studies.

cs.LG↗

arXiv2025

LLM Agent Swarm for Hypothesis-Driven Drug Discovery

Drug discovery remains a formidable challenge: more than 90 percent of candidate molecules fail in clinical evaluation, and development costs often exceed one billion dollars per approved therapy. Disparate data streams, from genomics and transcriptomics to chemical libraries and clinical records, hinder coherent mechanistic insight and slow progress. Meanwhile, large language models excel at reasoning and tool integration but lack the modular specialization and iterative memory required for regulated, hypothesis-driven workflows. We introduce PharmaSwarm, a unified multi-agent framework that orchestrates specialized LLM "agents" to propose, validate, and refine hypotheses for novel drug targets and lead compounds. Each agent accesses dedicated functionality--automated genomic and expression analysis; a curated biomedical knowledge graph; pathway enrichment and network simulation; interpretable binding affinity prediction--while a central Evaluator LLM continuously ranks proposals by biological plausibility, novelty, in silico efficacy, and safety. A shared memory layer captures validated insights and fine-tunes underlying submodels over time, yielding a self-improving system. Deployable on low-code platforms or Kubernetes-based microservices, PharmaSwarm supports literature-driven discovery, omics-guided target identification, and market-informed repurposing. We also describe a rigorous four-tier validation pipeline spanning retrospective benchmarking, independent computational assays, experimental testing, and expert user studies to ensure transparency, reproducibility, and real-world impact. By acting as an AI copilot, PharmaSwarm can accelerate translational research and deliver high-confidence hypotheses more efficiently than traditional pipelines.

cs.AI↗

arXiv2025

A Hybrid Chaos-Based Cryptographic Framework for Post-Quantum Secure Communications

We present CryptoChaos, a novel hybrid cryptographic framework that synergizes deterministic chaos theory with cutting-edge cryptographic primitives to achieve robust, post-quantum resilient encryption. CryptoChaos harnesses the intrinsic unpredictability of four discrete chaotic maps (Logistic, Chebyshev, Tent, and Henon) to generate a high-entropy, multidimensional key from a unified entropy pool. This key is derived through a layered process that combines SHA3-256 hashing with an ephemeral X25519 Diffie-Hellman key exchange and is refined using an HMAC-based key derivation function (HKDF). The resulting encryption key powers AES-GCM, providing both confidentiality and integrity. Comprehensive benchmarking against established symmetric ciphers confirms that CryptoChaos attains near-maximal Shannon entropy (approximately 8 bits per byte) and exhibits negligible adjacent-byte correlations, while robust performance on the NIST SP 800-22 test suite underscores its statistical rigor. Moreover, quantum simulations demonstrate that the additional complexity inherent in chaotic key generation dramatically elevates the resource requirements for Grover-based quantum attacks, with an estimated T gate count of approximately 2.1 x 10^9. The modular and interoperable design of CryptoChaos positions it as a promising candidate for high-assurance applications, ranging from secure communications and financial transactions to IoT systems, paving the way for next-generation post-quantum encryption standards.

cs.CR↗